Recent Comments

Comment RSS

Brachytherapy News and Research RSS Feed - Brachytherapy News and Research

Brachytherapy is a minimally invasive procedure that involves the use of radioactive seeds the size of rice grains. Brachytherapy, an out-patient procedure, usually takes 45 minutes to an hour to perform. Most patients can return to their normal activities within days. The success rates of prostate brachytherapy have compared favorably with success rates of radical prostatectomy and external beam radiation. In comparison studies, prostate brachytherapy has shown to have a favorable side effect profile when compared with other modalities. Clinical studies have shown that prostate brachytherapy has a cure rate of 94% for appropriately selected patients.

UCH introduces RapidArc technology from Varian Medical Systems

20. November 2009 00:55
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. [More]

PaxScan digital image detectors and X-ray tubes of Varian Medical Systems to be exhibited

19. November 2009 02:11
Varian Medical Systems, Inc., a premier supplier of X-ray tubes and flat panel digital image detectors, will exhibit its PaxScan digital image detectors and its line of X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the MEDICA 2009 International Trade Fair in Dusseldorf, Germany from November 18-21, 2009. [More]

Posted in: Device / Technology News

Tags: , , , ,

First-quarter fiscal 2010 results announced by IsoRay

16. November 2009 08:58
IsoRay Inc. a medical isotope company focusing on the treatment of prostate, lung, head and neck and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the first quarter of fiscal year 2010, ended September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

SAVI reaches a major milestone in breast brachytherapy

10. November 2009 05:08
This month marks three years since physicians began offering SAVI™ radiation treatment as part of breast conservation therapy for early-stage breast cancer – a major milestone in breast brachytherapy. [More]

Posted in: Device / Technology News | Women's Health News

Tags: , , ,

Chicago Prostate Cancer Center offers free prostate cancer guide

9. November 2009 09:21
Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society. [More]

Posted in: Men's Health News | Device / Technology News

Tags: , , ,

SAVI 6-1Mini applicator is the only brachytherapy solution for patients with small breasts, says study

6. November 2009 01:46
The SAVI™ 6-1Mini breast brachytherapy applicator is the only brachytherapy solution for patients with small breasts, hard-to-reach lumpectomy cavities, or cavities close to the skin surface, according to a new study. [More]

Posted in: Device / Technology News | Women's Health News

Tags: , , , , ,

Study suggests three-week course of radiation therapy effective for breast cancer patients

5. November 2009 02:57
According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant side effects. [More]

Posted in: Women's Health News

Tags: , , , , ,

Short, intensive radiation therapy offers similar results as conventional therapy for early stage-breast cancers

5. November 2009 01:48
According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant sides effects. [More]

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

4. November 2009 08:33
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois. [More]

AAPM Task Group issues new radiation guidelines for brachytherapy

3. November 2009 04:09
Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of Medical Physics in the department of Radiation Oncology at Thomas Jefferson University. [More]

Posted in: Medical Procedure News | Medical Condition News

Tags: , , , ,

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

31. October 2009 02:19
According to the American Cancer Society, more than one million people are diagnosed with cancer each year. In the United States, about 1 out of every 2 men and 1 out of every 3 women will have some type of cancer at some point during their lifetime. The sooner a cancer is detected and treatment begins, the better the patient’s chances for survival. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , ,

Cancer patients in northern Portugal to gain access to advanced cancer treatments

30. October 2009 08:54
Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the Instituto Portugues Oncologia, IPO Porto. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , ,

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

30. October 2009 00:53
TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer. [More]

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

29. October 2009 09:25
New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week. [More]

Posted in: Device / Technology News

Tags: , , , , , ,

World’s first Cesium-131 lung implants performed

29. October 2009 09:12
IsoRay, Inc. announced today that starting on August 12, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, and Dr. Nasser Altorki of the Department of Cardiothoracic Surgery at Weill Cornell Medical Center performed the world’s first Cesium-131 lung implants. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.